Resveratrol inhibits STAT5 activation through the induction of SHP-1 and SHP-2 tyrosine phosphatases in chronic myelogenous leukemia cells : Anti-Cancer Drugs

Journal Logo

PRECLINICAL REPORTS

Resveratrol inhibits STAT5 activation through the induction of SHP-1 and SHP-2 tyrosine phosphatases in chronic myelogenous leukemia cells

Li, Qinga,*; Zhang, Lib,*; Ma, Lia; Bai, Xuea; Li, Xina; Zhao, Mingfenga; Sui, Taoa

Author Information
Anti-Cancer Drugs 29(7):p 646-651, August 2018. | DOI: 10.1097/CAD.0000000000000635

Abstract

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid